サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1794514

針を使わない糖尿病治療の世界市場

Needle Free Diabetes Care

出版日
ページ情報
英文 284 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.92円
針を使わない糖尿病治療の世界市場
出版日: 2025年08月20日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 284 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

針を使わない糖尿病治療の世界市場は2030年までに168億米ドルに達する見込み

2024年に131億米ドルと推定される針を使わない糖尿病治療の世界市場は、分析期間2024-2030年にCAGR 4.2%で成長し、2030年には168億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるインスリン注入器は、CAGR 3.2%を記録し、分析期間終了時には56億米ドルに達すると予想されます。インスリンパッチセグメントの成長率は、分析期間でCAGR 5.2％と推定されます。

米国市場は36億米ドルと推定、中国はCAGR 7.5％で成長予測

米国の針を使わない糖尿病治療市場は2024年に36億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに34億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは7.5%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.8%と3.2%と予測されています。欧州では、ドイツがCAGR 2.5%で成長すると予測されています。

世界の針なし糖尿病ケア市場- 主要動向と促進要因のまとめ

なぜ針を使わない糖尿病治療が慢性疾患管理で注目されているのか？

針を使わない糖尿病ケア技術は、従来の針を使ったグルコースモニタリングやインスリン投与に伴う不快感、不便さ、リスクに対処するために開発・採用されています。多くの患者にとって、繰り返し指を刺したりインスリンを注射したりすることは、痛み、皮膚の炎症、不安を引き起こし、治療のアドヒアランスに影響を与える可能性があります。針を使わないシステムは、痛みのない、使いやすい、非侵襲的または最小侵襲的な代替手段を提供することで、患者のコンプライアンスを改善することを目的としています。

これらの技術には、経皮パッチ、ジェットインジェクター、レーザーベースのデバイス、マイクロニードルアレイ、間質液、汗、光信号を利用する非侵襲的グルコースモニターなどがあります。ウェアラブル持続グルコースモニター（CGM）やスマートセンサーは、手動によるモニタリングに取って代わりつつあります。インスリン投与とモニタリング機能を統合したデバイスも出現しており、より正確で個別化された血糖コントロールを可能にしています。生活の質（QOL）と長期的な疾患の自己管理が重視されるようになり、こうした革新的なツールへの関心が高まっています。

新しい技術はどのようにアクセシビリティと効率を高めているのか？

バイオセンサー技術、小型化、および無線通信の開発により、より正確で応答性の高い無針ソリューションの開発が推進されています。皮膚センサーを使用するCGMは現在、スマートフォンまたはインスリンポンプにリアルタイムでデータを送信し、物理的な中断なしに継続的な追跡を可能にしています。注射針を使用せずに高圧の流路からインスリンを投与するジェットインジェクターは、投与精度の向上と組織外傷の軽減のために改良されています。

光学信号、電磁信号、超音波信号を用いた非侵襲的血糖モニタリング装置が活発に研究されているが、信頼できる精度を達成することは依然として課題です。デジタルヘルスプラットフォームは、ヘルスケアプロバイダーによる遠隔モニタリングや、より広範な慢性期ケアのエコシステムへの統合を可能にするため、これらの機器との連携が進んでいます。バッテリー効率、ユーザーインターフェイスデザイン、データ可視化ツールは、日常的な使いやすさと幅広い普及をサポートするために改善されつつあります。

どのエンドユーザーとケアモデルが無針ソリューションの需要を牽引しているか？

針なし糖尿病デバイスの主なユーザーには、快適性、利便性、より良い治療アドヒアランスを求める1型および2型糖尿病患者が含まれます。小児患者、高齢者、針恐怖症の患者は、特に非侵襲的なオプションから恩恵を受ける可能性が高いです。在宅ケアや遠隔ケアモデルは、コントロールを維持しながら診療所への来院を最小限に抑える自己操作型やウェアラブル・ソリューションの需要拡大に貢献しています。

ヘルスケアプロバイダーや糖尿病教育者もまた、患者の管理計画に針を使わないデバイスを取り入れて、患者との関わりを改善し、合併症を減らしています。薬局、遠隔医療プラットフォーム、保険プロバイダーは、個別化された医療計画の一環としてこれらの機器をサポートし始めています。糖尿病有病率が高く、臨床インフラが限られている地域では、無針技術は従来のヘルスケアシステムの負担を軽減する拡張性のある代替手段を提供します。

無針糖尿病治療市場の成長はいくつかの要因に牽引されている...

無針糖尿病治療市場の成長は、いくつかの要因によって牽引されています。世界の糖尿病有病率の増加により、より優れた、患者に優しい管理ツールが求められています。センサー技術、ウェアラブル電子機器、ワイヤレスデータ統合の進歩は、機器の性能とユーザーエクスペリエンスを向上させる。自己モニタリングと長期的な疾病管理に対する意識の高まりが、消費者の採用を後押しします。デジタルヘルスエコシステムの拡大により、無針デバイスとモバイルアプリおよびクラウドプラットフォームの統合が促進されます。小児・老年医療モデルでは、安全性とコンプライアンスを向上させる痛みのないソリューションが支持されます。規制当局の承認と非侵襲的診断への投資により、複数の地域で製品開発と市場開拓が加速しています。

セグメント

デバイスタイプ（インスリン注入器、インスリンパッチ、インスリンペン、インスリンポンプ、ジェットインジェクター）、エンドユーザー（ホームケアエンドユーザー、診断センターエンドユーザー、病院＆クリニックエンドユーザー）

調査対象企業の例

  • 3M Company
  • Akeso/D. Medical Industries（Spring pump）
  • Akra Dermojet
  • Antares Pharma, Inc.
  • Bioject Medical Technologies, Inc.
  • CeQur Corporation
  • Crossject SA
  • Echo Therapeutics Inc.
  • Endo International plc
  • European Pharma Group BV
  • Injex Pharma AG
  • Insulet Corporation（Omnipod）
  • Johnson & Johnson
  • MannKind Corporation
  • Medtronic PLC
  • NuGen Medical Devices（InsuJet）
  • Pancreum LLC
  • PharmaJet, Inc.
  • Tandem Diabetes Care, Inc.
  • Valeritas, Inc.
  • Zogenix, Inc.

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP37488

Global Needle Free Diabetes Care Market to Reach US$16.8 Billion by 2030

The global market for Needle Free Diabetes Care estimated at US$13.1 Billion in the year 2024, is expected to reach US$16.8 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2024-2030. Insulin Infuser, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$5.6 Billion by the end of the analysis period. Growth in the Insulin Patches segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.6 Billion While China is Forecast to Grow at 7.5% CAGR

The Needle Free Diabetes Care market in the U.S. is estimated at US$3.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.4 Billion by the year 2030 trailing a CAGR of 7.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Needle-Free Diabetes Care Market - Key Trends & Drivers Summarized

Why Is Needle-Free Diabetes Care Attracting Attention in Chronic Disease Management?

Needle-free diabetes care technologies are being developed and adopted to address the discomfort, inconvenience, and risks associated with traditional needle-based methods of glucose monitoring and insulin delivery. For many patients, repeated finger-pricking and insulin injections cause pain, skin irritation, and anxiety, which can impact adherence to treatment. Needle-free systems aim to improve patient compliance by offering painless, user-friendly, and non-invasive or minimally invasive alternatives.

These technologies include transdermal patches, jet injectors, laser-based devices, microneedle arrays, and non-invasive glucose monitors that use interstitial fluid, sweat, or optical signals. Wearable continuous glucose monitors (CGMs) and smart sensors are increasingly replacing manual monitoring. Devices that integrate insulin delivery with monitoring capabilities are also emerging, allowing for more precise and personalized glycemic control. The increasing emphasis on quality of life and long-term disease self-management is fueling interest in these innovative tools.

How Are Emerging Technologies Enhancing Accessibility and Efficiency?

Advancements in biosensor technology, miniaturization, and wireless communication are driving development of more accurate and responsive needle-free solutions. CGMs using skin sensors now transmit real-time data to smartphones or insulin pumps, enabling continuous tracking without physical disruption. Jet injectors, which deliver insulin through high-pressure streams without needles, are being refined to offer better dosing accuracy and reduced tissue trauma.

Non-invasive blood glucose monitoring devices using optical, electromagnetic, or ultrasound signals are under active research, although achieving reliable accuracy remains a challenge. Digital health platforms are increasingly linked with these devices, allowing remote monitoring by healthcare providers and integration into broader chronic care ecosystems. Battery efficiency, user interface design, and data visualization tools are being improved to support daily usability and broader adoption.

Which End-Users and Care Models Are Driving Demand for Needle-Free Solutions?

The primary users of needle-free diabetes devices include type 1 and type 2 diabetes patients seeking comfort, convenience, and better treatment adherence. Pediatric patients, elderly individuals, and needle-phobic users are particularly likely to benefit from non-invasive options. Home-based and remote care models are helping expand demand for self-operated and wearable solutions that minimize clinic visits while maintaining control.

Healthcare providers and diabetes educators are also incorporating needle-free devices into patient management plans to improve engagement and reduce complications. Pharmacies, telemedicine platforms, and insurance providers are beginning to support these devices as part of personalized health plans. In regions with high diabetes prevalence and limited clinical infrastructure, needle-free technologies offer scalable alternatives that reduce the burden on traditional healthcare systems.

Growth in the Needle-Free Diabetes Care Market Is Driven by Several Factors…

Growth in the needle-free diabetes care market is driven by several factors. Increasing diabetes prevalence worldwide demands better and more patient-friendly management tools. Advancements in sensor technology, wearable electronics, and wireless data integration improve device performance and user experience. Rising awareness of self-monitoring and long-term disease control supports consumer adoption. Expansion of digital health ecosystems encourages the integration of needle-free devices with mobile apps and cloud platforms. Pediatric and geriatric care models favor painless solutions that improve safety and compliance. Regulatory approvals and investment in non-invasive diagnostics are accelerating product development and market entry across multiple regions.

SCOPE OF STUDY:

The report analyzes the Needle Free Diabetes Care market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Device Type (Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps, Jet Injectors); End-Use (Homecare End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • 3M Company
  • Akeso/D. Medical Industries (Spring pump)
  • Akra Dermojet
  • Antares Pharma, Inc.
  • Bioject Medical Technologies, Inc.
  • CeQur Corporation
  • Crossject SA
  • Echo Therapeutics Inc.
  • Endo International plc
  • European Pharma Group BV
  • Injex Pharma AG
  • Insulet Corporation (Omnipod)
  • Johnson & Johnson
  • MannKind Corporation
  • Medtronic PLC
  • NuGen Medical Devices (InsuJet)
  • Pancreum LLC
  • PharmaJet, Inc.
  • Tandem Diabetes Care, Inc.
  • Valeritas, Inc.
  • Zogenix, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Needle Free Diabetes Care - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Discomfort With Traditional Injections Spurs Demand for Needle-Free Diabetes Management Solutions
    • Increased Adoption of Jet Injectors and Transdermal Delivery Systems Throws Spotlight on Pain-Free Alternatives
    • Rising Diabetes Prevalence Globally Strengthens Business Case for User-Friendly, Non-Invasive Technologies
    • OEM Innovation in Patch-Based and Microneedle-Free Insulin Delivery Enhances Convenience and Compliance
    • Advancements in Continuous Glucose Monitoring (CGM) and Non-Invasive Sensors Drive System Integration
    • Patient Preference for Less Intrusive, Home-Based Care Supports Transition to Needle-Free Devices
    • Technological Breakthroughs in Ultrasonic, Iontophoretic, and Laser-Based Insulin Delivery Propel Market Differentiation
    • Government Focus on Improving Diabetes Management Infrastructure Encourages Inclusion of New Delivery Options
    • Growing Pediatric and Geriatric Diabetic Population Fuels Need for Gentle and Easy-to-Use Delivery Methods
    • Expansion of Telemedicine and Remote Patient Monitoring Strengthens Use of Portable Needle-Free Devices
    • Shift Toward Wearable and App-Connected Devices Supports Adoption in Tech-Savvy Urban Populations
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Needle Free Diabetes Care Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Needle Free Diabetes Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Needle Free Diabetes Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Insulin Infuser by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Insulin Infuser by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Insulin Infuser by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Insulin Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Insulin Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Insulin Patches by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Insulin Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Insulin Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Insulin Pens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Insulin Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Insulin Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Insulin Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Jet Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Jet Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Jet Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Homecare End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Homecare End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Homecare End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • JAPAN
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • CHINA
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: China 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • EUROPE
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Needle Free Diabetes Care by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Needle Free Diabetes Care by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • FRANCE
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: France 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • GERMANY
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Needle Free Diabetes Care by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Needle Free Diabetes Care by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • INDIA
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: India 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Needle Free Diabetes Care by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Needle Free Diabetes Care by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Needle Free Diabetes Care by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Needle Free Diabetes Care by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • AFRICA
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION